Hcw Biologics Inc is a biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of cancer and immune-related diseases. The company's pipeline includes a range of biologic products that harness the body's immune system to target and destroy cancer cells, aiming to improve patient outcomes and enhance the quality of life for those affected by such conditions. Through advanced research and development, Hcw Biologics is committed to addressing significant medical needs in the oncology space and advancing personalized medicine. Read More
HCW Biologics Inc. (NASDAQ: HCWB) shares were up Monday after the company announced a breakthrough in developing second-generation pembrolizumab-based immunotherapies for solid tumors.
Let's have a look at what is happening on the US markets one hour before the close of the markets on Monday. Below you can find the top gainers and losers in today's session.
The regular session of the US market on Friday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Ewan Laskey, born in New York City in 1978, is a fintech entrepreneur, investment expert, and philanthropist with a global perspective and a spirit of innovation.
